Even compared with other jobs in healthcare — an industry that made it through the heart of the recession rather gracefully — the job outlook for registered nurses is strong, with the number of jobs growing at an above-average rate.But nursing schools are slow to change, and in order to graduate successful nurses who are [...]

An Indiana neuroscience pharmaceutical company hopes it can gain entry into the market for Alzheimer’s disease treatment with experimental drugs it thinks could prevent the progression of the disease in the growing population of seniors.Based on the work of Dr. Michela Gallagher of John Hopkins University, AgeneBio of Indianapolis is working to slow the progression [...]

Eli Lilly is withdrawing Xigris from markets worldwide after a major study showed the drug doesn’t work for sepsis.I thought it would be a good time to rerun my post from earlier this year about conflict of interest problems with Xigris:An Archives of Internal Medicine article (Conflicts of Interest in Cardiovascular Clinical Practice Guidelines) [...]

When the topic of the 2.3 percent medical device excise tax arises, Cook Medical‘s Scott Sewell is quick to frame the discussion around jobs.Of Bloomington, Indiana-based Cook’s roughly 10,000 employees, 6,000 work in the United States; 525 in the company’s endoscopy unit in Winston-Salem, North Carolina. Sewell said that although the company has two new [...]

DePuy Orthopaedics has a new man in the corner office, now that it’s named veteran Andrew Ekdahl president of the Johnson & Johnson (NYSE:JNJ) subsidiary.Ekdahl will replace David Floyd, who resigned in March amid a damaging recall of one of DePuy’s hip replacement lines that’s already cost the company nearly $1 [...]

Earlier this month, Indiana University announced a major commitment to research in one of healthcare’s most promising fields, personalized medicine. The Indiana Institute for Personalized Medicine will pursue genome-based and pharmacogenomics studies in cardiology, pediatrics, obstetrics and cancer, as well as other areas. The emergence of personalized medicine, which targets individualized treatment and care based on personal and genetic variation, is creating a thriving market. Indeed, the market for personalized medicine in the United States is $232 billion and is projected to grow 11% annually.

Tuberculosis, diabetes and lupus are among the diseases targeted by Aarden Pharmaceuticals, based in Indiana. The company’s technology inhibits protein tyrosine phosphatases, a step which scientists have long believed will unlock new treatments for an array of ailments.

Leveraged buyout company The Riverside Co. has purchased an Indiana-based maker of orthodontics equipment. Riverside has made 48 healthcare acquisitions since its founding in 1988, but the G&H deal marks its first foray into orthodontia.

A bipartisan group of 15 senators sent a letter to FDA Commissioner Dr. Margaret Hamburg urging her agency, among other things, to adopt a more deliberate, cautious approach to amending 510(k). And Orthopedics company Stryker Corp. has agreed to sell a product line including the bone growth putty that has caused the company so much legal grief to Olympus Corp. for $60 million.

Federal prosecutors blasted Stryker Corp.’s (NYSE:SYK) biotech subsidiary, its former president and three sales reps for seeking the dismissal of the bulk of the 16 criminal charges pending against them in a federal case alleging the illegal promotion of bone putties.Hopkinton, Mass.-based Stryker Biotech, former president Mark Philip and the [...]